How to ride the ASX infant formula boom in 2020

Chinese demand has driven the share prices of several big-name ASX infant formula companies like A2 Milk Company Ltd (ASX: A2M) higher. How can you ride this boom in 2020?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Chinese demand for Aussie infant formula has driven the share prices of several big-name ASX companies higher in 2019.

The A2 Milk Company Ltd (ASX: A2M) share price has rocketed more than 2000% higher in the last 5 years and remains the incumbent amongst the ASX-listed dairy companies.

Just a week ago we saw the Bellamy's Australia Ltd (ASX: BAL) share price surge 48.7% higher last Monday morning (16 September), after receiving a $1.5 billion takeover offer from the Chinese group China Mengniu Dairy Company Limited.

So, is it too late to get in on the ASX infant formula action, or are there still buying opportunities available for the keen-eyed Fool?

What's the deal with Bellamy's?

The potential takeover of Bellamy's took investors by surprise over the weekend with Mengniu offering $12.65 per share and a $0.60 special dividend per share – a hefty premium on Bellamy's pre-takeover price of $8.32 per share.

While the Bellamy's board has unanimously recommended the deal, I'd expect to see the deal to be scrutinised by the Foreign Investment Review Board (FIRB) given the current concerns over foreign ownership in Australia.

Bellamy's has been seeking approval from the Chinese regulator to sell its products into China for some time, and this partnership with Mengniu would increase its capabilities to challenge a2 Milk's dominance in the Asian market.

Is there time to buy ASX infant formula shares?

When looking to invest in Aussie infant formula groups, a2 Milk and Bellamy's remain the largest and most well-known companies on offer.

However, if you feel like you've missed the astronomical share price growth from either of these two groups, there is still hope for your ASX portfolio.

Bubs Australia Ltd (ASX: BUB) is primarily a goat milk infant formula group and another contender in the industry, with the Bubs share price nearly doubling in the last 12 months alone.

In June 2019, Bubs announced a new Chinese partnership of its own with leading Chinese baby retailer Kidswant and saw its shares surge higher in May as it announced it would be venturing into cow milk infant formula as well.

Bubs currently boasts a market cap of $624.3 million, which pales in comparison to the size of a2 Milk ($9.26 billion) or Bellamy's ($1.46 billion), but is larger than the $87.5 million Wattle Health Australia Ltd (ASX: WHA).

Foolish takeaway

Time will tell if the Bellamy's takeover will be approved, but there is no doubt the race to capture the Chinese infant formula market is heating up.

It's worth keeping an eye on some of these top Aussie infant formula stocks in 2020 to see if there are tactical buying opportunities in the early part of the year.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Mergers & Acquisitions

APM share price placed on ice as $1.8 billion deal goes dud

It's all question marks and raised eyebrows for shareholders of this ASX company today.

Read more »

Young man sitting at a table in front of a row of pokie machines staring intently at a laptop. looking at the Crown Resorts share price
Mergers & Acquisitions

Could Star Entertainment shares be next in line to catch a takeover bid?

Star shares have been battered, but could a buyout be coming?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Bank Shares

Own CBA shares? Here's the tech stock the banking giant just invested in

CBA has made an interesting investment. Here's what you need to know.

Read more »

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX 300 stock is rocketing 10% on a $985 million cash bid!

Investors are piling into the ASX 300 stock on the back of a $985 million cash takeover bid.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Mergers & Acquisitions

Guess which ASX blue-chip share is throwing $202 million at another acquisition

This Aussie healthcare company is growing its presence in Switzerland.

Read more »

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

Boral share price falls after rejecting Seven Group takeover

The offer 'undervalues' Boral according to its committee.

Read more »

Miner looking at a tablet.
Materials Shares

Mineral Resources share price marching higher on new lithium project acquisition

ASX 200 investors are bidding up the Mineral Resources share price on Monday.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Appen shares plunges 17% after takeover collapse

Well that didn't take long...

Read more »